Nationwide Children's Hospital Interventional Cardiology : Page 1

interventional cardiology :: contact John.Cheatham@NationwideChildrens.org Interventional Cardiology is an internationally recognized program that provides a full spectrum of diagnostic and interventional cardiac catheterization procedures, with over 398 cardiac catheterizations performed per year The Heart Center offers state-of-the-art technology including two custom-built Hybrid Cardiac Catheterization laboratories that are equipped to provide interventional treatment of patients with congenital and acquired heart disease of all ages from a 700g premature infant to an 80-year-old adult This includes interventional transcatheter therapy of adult patients with congenital or structural heart disease expertise :: Staged hybrid therapy of patients with hypoplastic left heart syndrome :: Other hybrid and intraoperative interventional procedures :: Transcatheter implantation of the pulmonary valve (Melody) :: Closure of atrial and ventricular septal defects :: Closure of patent ductus arteriosus (including infants weighing less than 5kg) :: Treatment of patients with complex pulmonary artery obstructions :: Treatment of patients with coarctation of the aorta and complex arch obstructions :: Interventional catheterization procedures in very premature infants specialties :: expanding the concept of hybrid procedures to develop new therapeutic strategies :: Interventional research: – Selected trials: Melody trial, reSPeCT, reDUCe, ASO and muscular VSD occluder post-market studies, Angiomax, Nit-Occlude – research registry participation: CCISC, MAGIC – Member of the IMPACT working group of the ACPC 8/9

Interventional Cardiology

Interventional Cardiology is an internationally recognized program that provides a full spectrum of diagnostic and interventional cardiac catheterization procedures, with over 398 cardiac catheterizations performed per year. The Heart Center offers state-of-the-art technology including two custom-built Hybrid Cardiac Catheterization laboratories that are equipped to provide interventional treatment of patients with congenital and acquired heart disease of all ages from a 700g premature infant to an 80-yearold adult. This includes interventional transcatheter therapy of adult patients with congenital or structural heart disease.<br /> <br /> <b>expertise</b><br /> <br /> :: Staged hybrid therapy of patients with hypoplastic left heart syndrome <br /> :: Other hybrid and intraoperative interventional procedures<br /> :: Transcatheter implantation of the pulmonary valve (Melody)<br /> :: Closure of atrial and ventricular septal defects<br /> :: Closure of patent ductus arteriosus (including infants weighing less than 5kg)<br /> :: Treatment of patients with complex pulmonary artery obstructions<br /> :: Treatment of patients with coarctation of the aorta and complex arch obstructions<br /> :: Interventional catheterization procedures in very premature infants<br /> <br /> <b>specialties</b><br /> <br /> :: Expanding the concept of hybrid procedures to develop new therapeutic strategies<br /> :: Interventional research:<br /> <br /> – Selected trials: Melody trial, RESPECT, REDUCE, ASO and muscular VSD occluder post-market studies, Angiomax, Nit-Occlude<br /> <br /> – Research registry participation: CCISC, MAGIC <br /> <br /> – Member of the IMPACT working group of the ACPC<br /> <br /> <b>success</b><br /> <br /> Quality improvement and risk adjustment: Participation in national and international quality improvement efforts including C3PO and MAGIC registries.

Next Page


Publication List
 
Loading